SWITZERLAND/US: ROCHE TO USE CHIRON TECHNOLOGY
Article Abstract:
In a partial solution to their patent dispute, Roche and Chiron Corp. of Emeryville, California, have agreed upon the Swiss pharmaceutical maker using the US company's patents for nucleic acid probes in the production of hepatitis C and HIV tests based on polymerase chain reaction.
Publication Name: Chemische Rundschau
Subject: Pharmaceuticals and cosmetics industries
ISSN: 0009-2983
Year: 2000
User Contributions:
Comment about this article or add new information about this topic:
NETHERLANDS/SWITZERLAND: ORGANON/ROCHE DEAL
Article Abstract:
Roche Diagnostics has acquired from Organon Teknika a licence to the latter's Boom technology for the extraction of nucleic acid out of biological samples such as blood, serum, plasma, urine, faeces and saliva. The technology is based on silicon dioxide and guanidine thiocyanate
Publication Name: Chemische Rundschau
Subject: Pharmaceuticals and cosmetics industries
ISSN: 0009-2983
Year: 1999
User Contributions:
Comment about this article or add new information about this topic:
NETHERLANDS: ORGANON ACQUIRES DELTA DRUG
Article Abstract:
Organon
Publication Name: Chemische Rundschau
Subject: Pharmaceuticals and cosmetics industries
ISSN: 0009-2983
Year: 1999
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: SWITZERLAND/GERMANY: FOAMING AGENTS BY CLARIANT. SWITZERLAND: AXANTIS SUCCESSFUL WITH CELLULOSE. SWITZERLAND: ATISHOLZ TO GROW IN CHEMICALS
- Abstracts: GERMANY/US: MERCK, PRAXAIR END COOPERATION. GERMANY/US: DRAGOCO/COLLABORATIVE LABORATORIES. GERMANY/FRANCE: COSMETIC INGREDIENTS ALLIANCE
- Abstracts: GERMANY/US: BASF UPS HAFB OUTPUT. GERMANY: HAFB BOOST BY BASF. GERMANY: BAYER EXPANDS CAPACITY IN LEVERKUSEN
- Abstracts: US: KNOLL TO PAY DAMAGES. GERMANY/US: KNOLL, MYOGEN IN RESEARCH DEAL. GERMANY/US: BAYER, MYRIAD R&D INTO OBESITY
- Abstracts: GERMANY: ATRIX CANCER DRUG BY MEDIGENE. SWITZERLAND: EUROPEAN HEADQUARTERS FOR SUGEN. SWITZERLAND/US: ROCHE, OSI IN CANCER R&D DEAL